While its a less invasive option, it lacks FDA approval and has limited clinical evidence, which can make results more unpredictable
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
STEARIC ACID
Storage 4 C/-20 C Storage Comment Store undiluted at 2-8 C for one month or (in aliquots) at -20 C for longer
Originally developed to manage type 2 diabetes, Semaglutide has been shown to significantly reduce body weight by working on the brains appetite-regulating centers
We have convenient locations to serve you in Catonsville , Glen Burnie , Columbia , Rosedale , Edgewater , North Baltimore, MD